Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LQ036 in Poorly Controlled Asthma
NCT07589439Phase 2Recruiting
- Sponsor
- Novamab Biopharmaceuticals
- Start
- Sep 2025
- Primary completion
- Sep 2027
- Modality
- Antibody Conjugates, Nanobodies (VHH), Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of LQ036 in asthma, sponsored by Novamab Biopharmaceuticals. Started Sep 2025; status: recruiting.
02
Drugs
LQ036
03
Conditions
asthma
Beyond the preview
Go deeper on NCT07589439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07589439.